Paulo César Trindade Costa

Prof. Paulo César Trindade Costa

Federal University of Paraíba, João Pessoa, Paraíba, Brazil
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
DJDonia Jerab
Donia Jerab
FBFerdinand Blangero
Ferdinand Blangero
PCPaulo César Trindade Costa
Paulo César Trindade Costa
JAJosé Luiz de Brito Alves
José Luiz de Brito Alves
RKRym KEFI
Rym KEFI
Assia EljaafariAssia Eljaafari
Assia Eljaafari
Omega-3 polyunsaturated fatty acids (n-3 PUFAs) are known to help resolve inflammation through generation of anti-inflammatory eicosanoids and specialized pro-resolving mediators, including resolvins, protectins, and maresins. Through binding to the GPR120/FFAR4 receptor, their beneficial effects result from phospholipid membrane remodeling, impairment of inflammatory signaling molecules clustering, subsequent inhibition of NF-κB and inflammasome activation, and a reduction in oxidative stress. Obesity, a chronic inflammatory disease that contributes to metabolic disorders, is alleviated by n-3 PUFAs. In the adipose tissue (AT) of individuals with obesity, n-3 PUFAs counteract hypoxia, inhibit immune cell infiltration and AT inflammation, improve insulin sensitivity, and reduce fat mass. Beyond AT, n-3 PUFAs also alleviate other metabolic disorders such as metabolic-associated steatotic liver disease (MASLD), gut dysbiosis, and/or renal dysfunction. In cardiovascular disease (CVD), they are mainly recommended as a secondary prevention for patients with coronary heart disease risks. This review provides an in-depth analysis of the benefits of n-3 PUFAs in obesity and related metabolic diseases, examining both the mechanistic and clinical aspects. Additionally, it also explores the effects of n-3 PUFAs in obesity-related chronic inflammatory conditions, including inflammatory bowel disease, psoriasis, rheumatoid arthritis, osteoarthritis, and multiple sclerosis, by targeting specific pathophysiological mechanisms. Clinical applications and limitations of n-3 PUFAs are discussed based on findings from human clinical trials.

6 June 2023 in Foods
Verified
Journal Article
Open access
PDF file
PPPaula Pontes
Paula Pontes
ATAna Elisa Toscano
Ana Elisa Toscano
DLDiego Cabral Lacerda
Diego Cabral Lacerda
ESEulália Rebeca Silva-Araújo
Eulália Rebeca Silva-Araújo
PCPaulo César Trindade Costa
Paulo César Trindade Costa
RCRaul Manhães de Castro
Raul Manhães de Castro
Polyphenol supplementation during early life has been associated with a reduction of oxidative stress and neuroinflammation in diseases caused by oxygen deprivation, including cerebral palsy, hydrocephaly, blindness, and deafness. Evidence has shown that perinatal polyphenols supplementation may alleviate brain injury in embryonic, fetal, neonatal, and offspring subjects, highlighting its role in modulating adaptative responses involving phenotypical plasticity. Therefore, it is reasonable to infer that the administration of polyphenols during the early life period may be considered a potential intervention to modulate the inflammatory and oxidative stress that cause impairments in locomotion, cognitive, and behavioral functions throughout life. The beneficial effects of polyphenols are linked with several mechanisms, including epigenetic alterations, involving the AMP-activated protein kinase (AMPK), nuclear factor kappa B (NF-κB), and phosphoinositide 3-kinase (PI3K) pathways. To highlight these new perspectives, the objective of this systematic review was to summarize the understanding emerging from preclinical studies about polyphenol supplementation, its capacity to minimize brain injury caused by hypoxia-ischemia in terms of morphological, inflammatory, and oxidative parameters and its repercussions for motor and behavioral functions.

8 September 2022 in Foods
Verified
Journal Article
Open access
PDF file
PCPaulo César Trindade Costa
Paulo César Trindade Costa
JAJailane Aquino
Jailane Aquino
DLDiego Lacerda
Diego Lacerda
JNJosé Patrocinio Ribeiro Cruz Neto
José Patrocinio Ribeiro Cruz Neto
LSLudmilla Sales
Ludmilla Sales
JAJosé Luiz de Brito Alves
José Luiz de Brito Alves
Quercetin supplementation during pregnancy and lactation has been linked to a lower risk of maternal cardio-metabolic disorders such as gestational diabetes mellitus (GDM), dyslipidemia, preeclampsia, attenuation of malnutrition-related conditions, and gestational obesity in animal studies. Pre-clinical studies have shown that maternal supplementation with quercetin reduces cardio-metabolic diseases in dams and rodents’ offspring, emphasizing its role in modifying phenotypic plasticity. In this sense, it could be inferred that quercetin administration during pregnancy and lactation is a viable strategy for changing cardio-metabolic parameters throughout life. Epigenetic mechanisms affecting the AMP-activated protein kinase (AMPK), nuclear factor-kappa B (NF-κB), and phosphoinositide 3-kinase (PI3 K) pathways could be associated with these changes. To highlight these discoveries, this review outlines the understanding from animal studies investigations about quercetin supplementation and its capacity to prevent or decrease maternal and offspring cardio-metabolic illnesses and associated comorbidities.

19 November 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
CSCristiane Cosmo Silva-Luis
Cristiane Cosmo Silva-Luis
MLMariana Souza Lopes
Mariana Souza Lopes
SGSávio Marcelino Gomes
Sávio Marcelino Gomes
PMPalloma Karlla Cantalice Matias
Palloma Karlla Cantalice Matias
FBFernando Paiva Brandini
Fernando Paiva Brandini
JAJosé Luiz de Brito Alves
José Luiz de Brito Alves
Objective: To analyze the association between ultra-processed food (UPF) consumption and cardiometabolic, biochemical, and inflammatory risk factors in children in a metropolis in Northeast Brazil. Methods: A cross-sectional study using baseline data from a community-based controlled trial was carried out with 151 children from public schools in João Pessoa, Paraíba, Brazil aged 7 to 10 years. Dietary consumption was assessed using 24 h food recall, and UPF consumption was estimated using the NOVA classification system. Anthropometry (BMI for age), blood pressure, biochemical parameters (ALT, AST, GGT, cholesterol, LDL-c, HDL-c, triglycerides, fasting glucose, HbA1c, HOMA-IR, creatinine, urea, hs-CRP), and cytokines (IL-2, IL-4, IL-6, IL-10, IL-17a, IFN-γ, and TNF-α) were also assessed. Results: Children in the third tertile (highest UPF consumption) had higher serum concentrations of LDL-c (p-value = 0.04) and ALT (p-value = 0.01), with a trend towards higher AST (p-value = 0.06). Total energy (p-value = 0.01), trans fatty acid (p-value = 0.02), and sodium (p-value = 0.04) intakes were higher in the highest tertile, whereas protein (p-value < 0.01) and fiber (p-value < 0.01) intakes were lower. Concentrations of IL-17A (p-value = 0.01) and IL-10 (p-value = 0.04) were significantly higher in the second tertile. Multiple linear regression showed that UPF consumption was significantly associated with increased LDL-c, ALT, and AST concentrations. Conclusions: High intake of UPFs was associated with dyslipidemia, elevated liver enzymes, and inflammatory changes in children. Dietary interventions are needed to reduce UPF consumption and prevent cardiometabolic and liver disease in childhood.

16 August 2023 in Jornal de Pediatria
Verified
Journal Article
Open access
PCPaulo César Trindade Costa
Paulo César Trindade Costa
JSJoelma Rodrigues de Souza
Joelma Rodrigues de Souza
PLPoliana Correia Lima
Poliana Correia Lima
DDDavyson Barbosa Duarte
Davyson Barbosa Duarte
TNThallyta Alanna Ferreira Viana das Neves
Thallyta Alanna Ferreira Viana das Neves
JAJosé Luiz de Brito Alves
José Luiz de Brito Alves
Evaluate autonomic function and low-grade inflammation and characterize the correlation between these variables in schoolchildren with obesity living in the Brazilian northeast region. 84 children with obesity and 41 with normal weight were included in this cross-sectional study. Anthropometry, body composition, blood pressure (BP), inflammatory biomarkers, and heart rate variability (HRV) indexes were analyzed in children aged 7 to 11 years. children with obesity had increased systolic (p = 0.0017) and diastolic (p = 0.0131) BP and heart rate (p = 0.0022). The children with obesity displayed significantly lower SDNN, RMSSD, NN50, HF (ms), HF (nu), SD1, SD2, and higher LF (ms), LF (nu), LF/HF, SD1/SD2, DFA-α1, and DFA-α2, compared to normal weight. A lower and higher capacity for producing IL-10 (p = 0.039) and IL-2 (p = 0.009), respectively, were found in children with obesity compared to children with normal weight. Although IL-2, IL-4 and IL17A did not correlate with HRV parameters, IL-6 was positively correlated with SDNN, LF (ms) and SD2, TNF-α was positively correlated with LF/HF and SD1/SD2 ratio, and IFN-γ was positively correlated with SDNN, RMMSSD, NN50, LF (ms), HF (ms), SD1, and SD2. The findings suggest that children with obesity have impaired autonomic function and systemic low-grade inflammation compared to children within the normal weight range, the inflammatory biomarkers were correlated with HRV parameters in schoolchildren living in the northeastern region of Brazil.

14 March 2025 in Foods
Verified
Journal Article
Open access
PDF file
JBJéssica maria alves Brasil
Jéssica maria alves Brasil
NMNATHALIA CAROLINE DE OLIVEIRA MELO
NATHALIA CAROLINE DE OLIVEIRA MELO
KSKAROLINY SAMPAIO
KAROLINY SAMPAIO
PCPaulo César Trindade Costa
Paulo César Trindade Costa
HDHatice Duman
Hatice Duman
JAJosé Luiz de Brito Alves
José Luiz de Brito Alves
A promising strategy to improve the gut microbiome in hypertension is to target the gut microbiota. This study evaluated the effects of a potential nutraceutical product composed of three strains of Limosilactobacillus (L.) fermentum, quercetin, and resveratrol on the intestinal microbiome of healthy and hypertensive subjects. The nutraceutical product consisting of strains of L. fermentum 139, 263 and 296, fructooligosaccharides (200 mg), quercetin (160 mg), and resveratrol (150 mg) (LfQR) was added to the in vitro fecal fermentation process occurring for 48 h. Fecal samples of healthy and hypertensive subjects were allocated into four groups: (i) healthy controls (CTL); (ii) healthy controls with the addition of LfQR (CTL + LfQR); (iii) hypertensive (HTN) subjects; and (iv) hypertensive subjects with the addition of LfQR (HTN + LfQR). The diversity and composition of the fecal microbiota and the production of microbial metabolites were evaluated. CTL and HTN groups exhibited a distinct gut microbiota composition, as shown by the β-diversity assessment. The addition of the potentially nutraceutical-modulated β-diversity was similar between CTL and HTN groups, suggesting a similar gut microbiome composition after nutraceutical addition. The addition of the nutraceutical product increased the relative abundance of Enterobacteriaceae in the CTL group and that of Lachnospiraceae in the HTN group. The nutraceutical media showed higher levels of sugars (maltose, fructose, and glucose), lactic acid, ethanol, succinic acid, and acetic acid compared to the CTL and HTN media. Although the results are heterogeneous between healthy and hypertensive fermentation media, it was demonstrated that the nutraceutical formulation can modulate the intestinal microbiota and its metabolic activity.